Search clinical trials for: Grazax Placebo

Total 54026 results

Alkahest, Inc.

Completed

A Study to Evaluate the Effect of GRF6021 on Postoperative Recovery Following Primary Hip or Knee Arthroplasty

Postoperative Recovery

United States
University of Oklahoma

Withdrawn

Magnesphere for Autonomic Alteration

Hart Failure With Reduced Ejection Fraction

United States
NYU Langone Health

Completed

Study of the Duration and Efficacy of MYDAYIS on Adult ADHD Symptoms and Executive Function Throughout the Day Into the Early Evening (MYDAYIS)

Attention Deficit-Hyperactivity

United States
The Archer-Daniels-Midland Company
Atlantia Food Clinical Trials

Completed

Pilot Study to Assess the Effect of a Probiotic Blend on Moderate Self-reported Anxiety. (Anx)

Anxiety

Ireland
University of Minnesota

Completed

Combining tDCS and CILT in Non-fluent Aphasia

Stroke | Brain Injuries | Aphasia | Non-fluent Aphasia

United States
Hvidovre University Hospital

Completed

Physiological Responses to Laparoscopic Sleeve Gastrectomy: Focusing on Ghrelin

Bariatric Surgery

Denmark
Gan and Lee Pharmaceuticals, USA

Completed

A Study of GZR18 Injection in Chinese Obese/Overweight Patients

Obesity | Overweight

China
AstraZeneca
Amgen

Completed

Tezepelumab COPD Exacerbation Study (COURSE)

Chronic Obstructive Pulmonary Disease (COPD)

United States, Canada, Denmark, France, United Kingdom, Korea, Republic of, Germany, Israel, Spain, Netherlands
GlaxoSmithKline

Completed

Safety, Tolerability and Pharmacokinetics (PK) Investigation of GSK3494245 in Healthy Participants

Leishmaniasis

United Kingdom
Guangzhou Zhiyi Biotechnology Co., Ltd.

Completed

A Sequential Single and Multiple Ascending Dose (SAD/MAD) Study of SK10 Powders in Healthy Adult Subjects

Chemotherapy-induced Diarrhea

United States
Sonoma Biotherapeutics, Inc.

Active, not recruiting

Study of Single Doses of SBT115301 in Healthy Participants

Safety

United States
Braintree Laboratories

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Non-Erosive Reflux Disease

Non-erosive Reflux Disease

United States
AstraZeneca

Completed

Study to Assess the Efficacy and Safety of MEDI3506 in Adults With Uncontrolled Moderate-to-severe Asthma (FRONTIER-3)

Asthma

United States, Germany, United Kingdom, Argentina, Poland, South Africa, Hungary
Shanghai Hengrui Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis

Moderate to Severe Atopic Dermatitis

China
Novo Nordisk A/S

Active, not recruiting

A Research Study of How the Medicine Ziltivekimab Works in the Body of Chinese Men and Women With Kidney Disease and Inflammation

Chronic Kidney Disease and Systemic Inflammation

China
Tigenix S.A.U.

Completed

Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD) (ADMIRE-CD-II)

Crohn's Disease

United States, Spain, United Kingdom, Italy, Germany, Canada, Belgium, Denmark, Poland, Czechia, France, Hungary, Israel, Puerto Rico, Sweden
University of Exeter

Completed

'Oral Microbiome -Dietary Nitrate' Interactions and Cognitive Health in Older Age (COGNIT)

Dietary Supplementations

United Kingdom
SpineThera Australia PTY LTD

Terminated

Safety and Efficacy of SX600 Administered by Lumbosacral Transforaminal Epidural Injection for Radicular Pain (SALIENT)

Lumbar Radiculopathy

Australia
Jazz Pharmaceuticals

Active, not recruiting

A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JZP441 in Healthy Participants

Healthy Participants

United States
Endo Pharmaceuticals

Completed

Efficacy, Safety, and Tolerability, of EN3835 vs Placebo in the Treatment of Plantar Fibromatosis

Plantar Fibromatosis

United States
Jazz Pharmaceuticals

Completed

A Study of JZP150 in Adults With Posttraumatic Stress Disorder

Post Traumatic Stress Disorder

United States
Silence Therapeutics plc

Completed

A Study Investigate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Response of SLN124 in Adults With Alpha/Beta-thalassaemia and Very Low- and Low-risk Myelodysplastic Syndrome

Non-transfusion-dependent Thalassemia | Low Risk Myelodysplastic Syndrome | Very-Low Risk Myelodysplastic Syndrome

Thailand, Israel, Jordan, United Kingdom, Germany, Italy, Malaysia
Phathom Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo for Relief of Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD)

Heartburn | Non-Erosive Gastro-Esophageal Reflux Disease

United States
Eli Lilly and Company
Loxo Oncology, Inc.

Completed

A Study of LY3410738 in Healthy Adult Participants

Healthy

United States
Alector Inc.
AbbVie

Active, not recruiting

A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease (INVOKE-2)

Alzheimer Disease

United States, Spain, France, Germany, Australia, Canada, Poland, Italy, Argentina, Netherlands, United Kingdom, New Zealand
Sanofi

Completed

Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Single and Repeated Doses of SAR444336 in Healthy Adult Participants

Healthy Volunteer

Netherlands
Ionis Pharmaceuticals, Inc.

Completed

A Study to Assess the Safety, Tolerability, and Efficacy of Monthly Subcutaneous Administration of ION904 in Participants With Uncontrolled Hypertension

Hypertension

United States
Certa Therapeutics

Completed

Effects of FT011 in Systemic Sclerosis

Scleroderma, Systemic | Scleroderma, Diffuse | Sclerosis, Systemic

Australia, Netherlands, Poland, Spain, Ukraine
Seoul National University Hospital
Ensol Biosciences, Inc.

Completed

To Evaluate the Safety, Tolerability, and Pharmacokinetics After Subcutaneous Administration of C1K in Healthy Subjects

Healthy Subjects

Korea, Republic of
University of Aarhus
Future Food Innovation

Completed

Novel Organic Kale Products for Prevention of Obesity/Type 2 Diabetes

Type2 Diabetes

Denmark
Eli Lilly and Company

Completed

A Study of LY3451838 in Participants With Migraine

Migraine

United States
PhytoHealth Corporation

Completed

The Pilot Clinical Study of PG2 Injection on Hemorrhagic Stroke

Hemorrhagic Stroke

Taiwan
Prilenia

Active, not recruiting

PRidopidine's Outcome On Function in Huntington Disease, PROOF- HD

Huntington Disease

United States, Austria, Canada, Czechia, France, Germany, Italy, Netherlands, Poland, Spain, United Kingdom
Cargill
KGK Science Inc.

Completed

Effects of a Yeast Fermentate (EpiCor) Supplement on Cold or Flu Symptoms in Healthy Children

Signs and Symptoms, Respiratory

Canada
Eli Lilly and Company

Completed

Chronic Pain Master Protocol (CPMP): A Study of LY3016859 in Participants With Osteoarthritis

Osteoarthritis

United States, Puerto Rico
Organicell Regenerative Medicine

Suspended

Zofin to Treat Chronic Obstructive Pulmonary Disease (COPD)

COPD

United States
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS) (SUNRISE)

Hidradenitis Suppurativa

Belgium, Italy, United Kingdom, United States, Hungary, Malaysia, Germany, Netherlands, France, Israel, Lebanon, Singapore, Spain, Bulgaria, Lithuania, Argentina, Turkey, Guatemala, Switzerland, Vietnam, Philippines, Croatia, India, S... and more
Machaon Biotherapeutics, Inc.

Active, not recruiting

Multiple Ascending Dose Study of CG200745 'Ivaltinostat' Oral Capsule

Fibrosis | Solid Tumor | Hematologic Malignancy

Korea, Republic of
GlaxoSmithKline

Completed

Phase 1, Single and Repeat Dose Study to Assess Safety, Tolerability, and Pharmacokinetics (PK) of GSK3923868 in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

Germany
Tisento Therapeutics

Completed

Study to Assess the Safety and Pharmacokinetics of CY6463 in Participants With Stable Schizophrenia

Schizophrenia

United States
Biogen

Active, not recruiting

A Study to Assess the Safety, Tolerability, and Effect on Disease Progression of BIIB105 in Participants With Amyotrophic Lateral Sclerosis (ALS) and Participants With the ALS Ataxin-2 (ATXN2) Genetic Mutation (ALSpire)

Amyotrophic Lateral Sclerosis

United States, Netherlands, Italy, Canada
GlaxoSmithKline

Completed

Phase I Study of GSK2982772 in Japanese Healthy Male Participants

Autoimmune Diseases

Japan
Eisai Co., Ltd.

Completed

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of E6742 in Systemic Lupus Erythematosus Participants

Lupus Erythematosus, Systemic

Japan
Microphyt
University of Central Florida

Completed

Evaluation of the Effects of a Novel Dietary Microalgae Based Ingredient on Muscle Recovery and Endurance Capacity (PORPHY-ONE)

Healthy

United States
Ampio Pharmaceuticals. Inc.

Completed

A Study to Evaluate Ampion in Patients With Prolonged Respiratory Symptoms Due to COVID-19 (Long COVID)

Covid19

United States
Astellas Pharma Global Development, Inc.

Completed

A Study to Find Out How Safe Long-term Treatment With Fezolinetant is in Women With Hot Flashes Going Through Menopause (Skylight 4)

Hot Flashes

United States, Czechia, Canada, Latvia, Poland, Spain, Ukraine, United Kingdom
Galapagos NV

Terminated

A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome (pSS) (GLIDER)

Primary Sjögren Syndrome

Germany, Greece, Poland, Hungary, Ukraine
Kancera AB

Completed

Safety, Tolerability and Pharmacokinetics After Continuous Infusion of KAND567

Healthy

Finland
Dizal (Jiangsu) Pharmaceutical Co., Ltd.

Completed

A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics of DZD8586 in Healthy Adult Participants

Lymphoma, Non-Hodgkin

United States
AstraZeneca

Completed

Efficacy and Safety of MEDI7352 in Subjects With Painful Diabetic Neuropathy

Painful Diabetic Neuropathy

Poland, United Kingdom, Hungary, Denmark, Romania

3

Subscribe